Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.
Other companies in Aptevo Therapeutics’s space includes: Ernexa Therapeutics Inc (NASDAQ:ERNA), Alzamend Neuro Inc (NASDAQ:ALZN), Immuron Ltd (NASDAQ:IMRN), Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) and Imunon Inc (NASDAQ:IMNN).
Aptevo Therapeutics has a consensus price target of $8.00.
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $9.02 last updated January 16, 2026 at 9:29 AM EST.
There are no upcoming dividends for Aptevo Therapeutics.
Aptevo Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Aptevo Therapeutics.
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.